CGRP-REZEPTOR-ANTAGONISTEN

Patent europeic · EP3368525 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3368525
Numer da la dumonda: EP16791443
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 28-10-2016
Publitgà: 05-09-2018
Concedì: 13-03-2019
La protecziun finescha il pli tard: 27-10-2036
Proxima taxa annuala scadenta: 31-10-2026
Classas IPC: C07D 401/14 (2006.01)
C07D 498/10 (2006.01)
A61K 31/437 (2006.01)
A61K 31/537 (2006.01)
A61P 25/06 (2006.01)
Prioritad: GB 201519196 30.10.2015
Dumonda PCT: PCT/IB2016/056517 28.10.2016
Publicaziun PCT: WO2017/072721 04.05.2017
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-11-2025
Midada
Published in Swissreg on 01.11.2025
01-11-2024
Midada
Published in Swissreg on 01.11.2024
30-10-2024
Adressa dal possessur midada
Owner
Heptares Therapeutics Limited, Granta Park, Great Abington, Cambridge CB21 6DG, United Kingdom → Nxera Pharma UK Limited, Granta Park, Great Abington, Cambridge CB21 6DG, United Kingdom
Published in Swissreg on 30.10.2024
26-01-2024
Midada
Published in Swissreg on 26.01.2024
01-11-2022
Midada
Published in Swissreg on 01.11.2022
14-02-2020
Adressa midada
Representative
TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly → TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly
Published in Swissreg on 14.02.2020
25-04-2019
Represchentant inscrit
Representative
TR-IP Consulting LLC, Route de Coutset 18, 1485 Nuvilly
Published in Swissreg on 25.04.2019
13-03-2019
Concedì
Published in Swissreg on 13.03.2019

Granta Park Great Abington, Cambridge CB21 6DG, GB

TR-IP Consulting LLC

Route du Coutset 18, 1485 Nuvilly